NEOMED Institute Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 350

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

NEOMED Institute General Information

Description

Provider of industrial expertise in drug discovery and development intended for small and medium enterprises to take charge of what pharma companies were doing and to bridge the gap between academic innovation and industry needs.

Contact Information

Website
www.neomed.ca
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 7171 Frederick-Banting
  • Montreal, Quebec H4S 1Z9
  • Canada
+1 (514)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
adMare Bioinnovations
Corporate Office
  • 7171 Frederick-Banting
  • Montreal, Quebec H4S 1Z9
  • Canada
+1 (514)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NEOMED Institute Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NEOMED Institute‘s full profile, request access.

Request a free trial

NEOMED Institute Patents

  • 46

    Total Documents Applications and Grants

  • Total Patents Families

  • 30

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

NEOMED Institute Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3908574-A1 Crystalline forms of (s)-2-(7-cyano-1h-benzimidazol-1 yl)- n-{1-[4-(1-cyano-1-methylethyl)phenyl]ethyl}acetamide Inactive 08-Jan-2019
CA-3125655-A1 Crystalline forms of (s)-2-(7-cyano-1h-benzimidazol-1 yl)- n-{1-[4-(1-cyano-1-methylethyl)phenyl]ethyl}acetamide Pending 08-Jan-2019
AU-2020207426-A1 Crystalline forms of (s)-2-(7-cyano-1h-benzimidazol-1 yl)- n-{1-(4-(1-cyano-1-methylethyl)phenyl)ethyl}acetamide Inactive 08-Jan-2019
US-20220089550-A1 Crystalline forms of (s)-2-(7-cyano-1h-benzimidazol-1 yl)-n-{1-[4-(1-cyano-1-methylethyl)phenyl]ethyl}acetamide Inactive 08-Jan-2019
EP-3908574-A4 Crystalline forms of (s)-2-(7-cyano-1h-benzimidazol-1 yl)- n-{1-[4-(1-cyano-1-methylethyl)phenyl]ethyl}acetamide Inactive 08-Jan-2019 C07D235/16
To view NEOMED Institute’s complete patent history, request access »

NEOMED Institute Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NEOMED Institute FAQs

  • When was NEOMED Institute founded?

    NEOMED Institute was founded in 2012.

  • Where is NEOMED Institute headquartered?

    NEOMED Institute is headquartered in Montreal, Canada.

  • What is the size of NEOMED Institute?

    NEOMED Institute has 350 total employees.

  • What industry is NEOMED Institute in?

    NEOMED Institute’s primary industry is Biotechnology.

  • Is NEOMED Institute a private or public company?

    NEOMED Institute is a Private company.

  • What is NEOMED Institute’s current revenue?

    The current revenue for NEOMED Institute is .

  • When was NEOMED Institute acquired?

    NEOMED Institute was acquired on 30-May-2019.

  • Who acquired NEOMED Institute?

    NEOMED Institute was acquired by adMare Bioinnovations.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »